News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
01
2025
-
12
Building a Learning-Oriented Team (Lesson 17) | Deepen expertise in clean air conditioning operations and maintenance, and solidify the quality and safety defense line!
Classification：
行业新闻
Corporate News
To strengthen the professional capabilities of key positions and solidify the quality and safety barrier for pharmaceutical production, 13 On [date], Linuo Pharmaceutical organized a special training session on the topic of “Introduction to Clean Air Conditioning Systems and Management Requirements.” The training was led by Huang Fangsheng, the company’s president, and was aimed at personnel from the Lean Operations Center, the Quality Management Center, and the Engineering & Equipment Department. The goal was to systematically enhance the team’s understanding and practical skills related to clean air conditioning systems.
This training closely aligns with the core needs of pharmaceutical production. President Huang Fangsheng began by explaining the fundamental principles of air conditioning systems and, in conjunction with the requirements of the “Good Manufacturing Practice for Pharmaceutical Products,” used vivid illustrations and practical case analyses to help participants grasp the operational principles of these systems and their critical role in ensuring pharmaceutical quality. This approach has strengthened employees’ understanding of cleanroom air conditioning systems. “What is it, why is it, and how do we do it?” The theoretical foundation has also strengthened the practical capabilities for cross-departmental collaboration and coordination, providing professional support to ensure that sterile preparation production environments meet standards and to prevent cross-contamination. Participating employees unanimously expressed that the training content closely matched their actual job requirements and was highly practical. They pledged to flexibly apply the knowledge they’ve gained in their daily work, using their professional expertise to safeguard product quality.
As one of the key initiatives for “building a learning-oriented team,” the Linuo Pharmaceutical training series consistently focuses on: Care for life and health, safeguard a better life. Our corporate mission focuses on core technologies, regulatory standards, and practical skills, continuously empowering our employees’ growth. In the future, the company will continue to promote the development of a learning organization, providing robust talent and technological support to ensure drug safety and enhance production quality.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
2026-05-13
On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.
2026-05-07
On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.
2026-05-07
Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China